Burning Rock Biotech Files 6-K Report

Ticker: BNR · Form: 6-K · Filed: Jun 3, 2024 · CIK: 1792267

Sentiment: neutral

Topics: reporting, foreign-issuer

Related Tickers: BNR

TL;DR

Burning Rock Biotech (BNR) filed a 6-K, standard update for foreign issuers.

AI Summary

Burning Rock Biotech Limited filed a Form 6-K on June 3, 2024, incorporating by reference certain information from Exhibit 99.1. The filing pertains to the month of June 2024 and is for a foreign private issuer. The company's principal executive offices are located in Guangzhou, People's Republic of China.

Why It Matters

This filing indicates ongoing reporting activity for Burning Rock Biotech, providing updates to investors as required for foreign private issuers.

Risk Assessment

Risk Level: low — A 6-K filing is a routine report for foreign private issuers and does not typically contain material non-public information that would significantly alter risk.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the registrant makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.

What information is being incorporated by reference in this filing?

Exhibit 99.1 of this current report on Form 6-K is incorporated by reference, excluding specific sections related to Non-GAAP Measures and reconciliations.

Where is Burning Rock Biotech Limited's principal executive office located?

The principal executive offices are located at No.5 Xingdao Ring Road North, International Bio Island, Guangzhou, Guangdong, People's Republic of China.

What is the SEC file number for Burning Rock Biotech Limited?

The SEC file number for Burning Rock Biotech Limited is 001-39316.

What period does this Form 6-K report cover?

This Form 6-K report is for the month of June 2024.

Filing Stats: 219 words · 1 min read · ~1 pages · Grade level 13.2 · Accepted 2024-06-03 06:08:26

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Burning Rock Biotech Limited By: /s/ Leo Li Name: Leo Li Title: Chief Financial Officer Date: June 3, 2024 4

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing